Xiaohui Niu

5PUBLICATIONS
36CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 26, 2025
JMT103 versus Non-Denosumab or Denosumab Treatment in Chinese Patients with Unresectable or Surgically Challenging Giant Cell Tumor of Bone: A Propensity Score-Matched Comparison.

Hairong Xu, Yong Zhou, Feng Wei

|Nov 05, 2024
Efficacy and safety of JMT103 in patients with unresectable or surgically-challenging giant cell tumor of bone: a multicenter, phase Ib/II study.

Hairong Xu, Yong Zhou, Li Liang

|Sep 20, 2023
The correlation between clinical outcomes and genomic analysis with high risk factors for the progression of osteosarcoma.

Weifeng Liu, Huanqing Cheng, Zhen Huang

|May 08, 2023
A Retrospective Observational Study on Disease Characteristics and Treatment Patterns of Giant Cell Tumor of the Bone in China.

Hairong Xu, Yuan Li, Tao Wang

|Oct 07, 2020
Surgical Outcome and Oncological Survival of Osteofibrous Dysplasia-Like and Classic Adamantinomas: An International Multicenter Study of 318 Cases.

E M Schutgens, P Picci, D Baumhoer

Pageof 1

Frequent Collaborators

3 joint publications

Weifeng Liu

1 joint publications

E M Schutgens

1 joint publications

P Picci

1 joint publications

D Baumhoer